Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Published 10 July 2009, doi:10.1136/bmj.b2804
Cite this as: BMJ 2009;339:b2804
Janice Hopkins Tanne
1 New York
| The first 150 words of the full text of this article appear below. |
The US National Institutes of Health have released rules about the use of embryonic stem cell lines in research funded by the institutes. This follows Barack Obamas decision in March to remove the ban introduced by the previous US president, George Bush, on using federal funds to support embryonic stem cell research (BMJ 2009;338:b1011, doi:10.1136/bmj.b1011).
The rules state that the cells must come from embryos voluntarily donated for research with informed consent. They will come from donations of excess embryos by people treated at in vitro fertilisation clinics. The embryos would otherwise be discarded.
Donors must be informed during the consent process that they cannot make any restriction or direction about the use of the donated cells, such as who might be the recipients of cell transplants. They must also be told that the research is not intended to provide any direct benefit to them and that
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?